Impact of Age and Menopausal Status on T-DM1 (Ado-Trastuzumab Emtansine) Treatment Outcomes in HER2-Positive Breast Cancer. - Surmeli H; Isik D; Kinikoglu O; Altintas YE; Ozkerim U; Oksuz S; Basoglu T; Odabas H; Turan N (Pharmaceuticals (Basel, Switzerland), 2025)